Acute myeloblastic leukemia with minimal myeloid differentiation: Phenotypical and ultrastructural characteristics

Leukemia

Volumn 12, Issue 7, 1998, Pages 1071-1075

  Villamor, N ^a   Zarco, M A ^b   Rozman, M ^a   Ribera, J M ^b   Feliu, E ^b   Montserrat, E ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Acute myeloid leukemia; AML MO; Immunophenotype; Ultrastructure

Indexed keywords

ANTIGEN; CD22 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD7 ANTIGEN; FERRITIN; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; PEROXIDASE; UNCLASSIFIED DRUG;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CYTOPLASM; ERYTHROID CELL; FEMALE; GRANULOCYTE; HUMAN; KARYOTYPE; MALE; PHENOTYPE; PRIORITY JOURNAL; TDT; THROMBOCYTE;

EID: 0031874332     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401074     Document Type: Article

References (29)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-MO). Br J Haematol 1991; 78: 325-329.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report from the French-American-British cooperative group. Ann Intern Med 1985; 103: 460-462.
3. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Granick HR, Sultan C. Proposals for the classification of the acute leukaemias. Br J Haematol 1976; 33: 451-458.
4. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report from the French-American-British cooperative group. Ann Intern Med 1985; 103: 620-625.
5. Davey FR, Erber WN, Gatter KC, Mason DY. Immunophenotyping of acute myeloid leukemia by immunoalkaline phosphatase (APAAP) labelling with a panel of antibodies. Am J Hematol 1987; 26: 157-166.
6. Rozman C, Woessner S, Feliu E, Lafuente R, Berga L. Cell Ultrastructure for Hematologists. Doyma: Barcelona, 1993.
7. An International System for Human Cytogenetic Nomenclature. Recommendations of the International Standing Committee of Human Cytogenetic Nomenclature. Felix Mitelman (ed). Karger: Basel, 1995.
8. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1982.
9. Venditti A, Del Poeta G, Stasi R, Masi M, Bruno A, Buccisano F, Cox C, Coppetelli U, Aronica G, Simone MD, Tribaldo M, Amadori S, Papa G. Minimally differentiated acute myeloid leukemia (AML-MO): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases. Br J Haematol 1994; 88: 784-793.
10. Venditti A, del Poeta G, Stasi R, Buccisano F, Aronica G, Bruno A, Cox C, Maffei L, Tamburini A, Papa G, Amadori S. Biological profile of 23 cases of minimally differentiated leukemia (AML-MO) and its clinical implication (letter). Blood 1996; 87: 418-420.
11. Venditti A, Del Poeta G, Buccisano F, Tamburini A, Cox C, Stasi R, Bruno A, Aronica G, Maffei L, Suppo G, Simone MD, Forte L, Cordero V, Postorino M, Tufilli V, Isacchi G, Masi M, Papa G, Amadori S. Minimally differentiated acute myeloid leukemia (AML-MO): comparison of 25 cases with other French-American-British subtypes. Blood 1997; 89: 621-629.
12. Lepelley P, Preudhomme C, Sartiaux C, Ghevaert C, Lai JL, Iaru T, Fenaux P, Cosson A. Immunological detection of myeloperoxidase in poorly differentiated acute leukemia. Eur J Hematol 1993; 50: 155-159.
13. Urbano-Ispizua A, Matutes E, Villamor N, Sierra J, Pujades A, Reverter JC, Feliu E, Cervantes F, Vives-Corrons JL, Montserrat E, Rozman C. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia. Br J Haematol 1992; 81: 178-183.
14. Buccheri V, Shelly V, Yoshida N, Morilla R, Matutes E, Catovsky D. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry. Br J Haematol 1992; 80: 62-68.
15. Cuneo A, Ferrant A, Michaux JL, Boogaerts M, Demuynck H, van Orshoven A, Criel A, Stul M, Dal Clin P, Hernandez J, Chatelain B, Doyen C, Louwagie A, Castoldi C, Cassiman JJ, Van Den Berghe H. Cytogenetic profile of minimally differentiated (FAB MO) acute myeloid leukemia: correlation with clinicobiological findings. Blood 1995; 85: 3688-3694.
16. Stasi R, del Poeta C, Venditti A, Masi M, Stipa E, Dentamaro T, Cox C, Dallapiccola B, Papa G. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-MO). Blood 1994; 83: 1619-1625.
17. Drexler HG, Sperling C, Ludwig WD. Terminal deoxynucleotidyl tranferase (TdT) expression in acute myeloid leukemia. Leukemia 1993; 7: 1142-1150.
18. Drexler HG, Thiel E, Ludwig WD. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukemia 1993; 7: 489-498.
19. Basan R, Biondi A, Benvestito S, Tini ML, Abbate M, Viero P, Borleri G, Barbui T. Acute undifferentiated leukemia with CD7+ and CD13+ immunophenotype. Lack of molecular commitment and association with poor prognostic features. Cancer 1992; 69: 396-404.
20. Vidrales MB, Orfao A, Gonzalez M, Hernández JM, López-Berges MC, Garcia MA et al. Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia. Leukemia 1993; 12: 2026-2029.
21. Yokose N, Ogata K, Ito T, Miyake K, An E, Inokuchi K, Yamada T, Gomi S, Tanabe Y, Ohki I, Kuwabara T, Hasegawa S, Shinohara T, Dan K, Nomura T. Chemotherapy for minimally differentiated acute myeloid leukemia (AML-MO). A report of five cases and review of the literature. Ann Hematol 1993; 66: 67-70.
22. Matutes E, Catovsky D. The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B-cell disorders. Leuk Lymphoma 1994; 13 (Suppl. 1): 11-14.
23. Vainchenker W, Villeval JL, Tabilio A, Matamis H, Karianakis G, Guichard J et al. Immunophenotype of leukemic blasts with small peroxidase-positive granules detected by electron microscopy. Leukemia 1988; 2: 274-281.
24. Heil G, Gunsilius E, Hoelzer D, Thiel E, Heimpel H. Peroxidase expression in acute unclassified leukemias: ultrastructural studies in combination with immunophenotyping. Leuk Lymphoma 1994; 14: 103-109.
25. Breton-Gorius J. Review of the ultrastructural and cytochemistry of megakaryoblastic leukemia. In Poliack A (ed). Human Leukemias. Martinus Nijhoff: Boston, 1984, pp 63-92.
26. Koike T. Megakaryoblastic leukemia: the characterization and identification of megakaryoblasts. Blood 1984; 64: 683-692.
27. Segeren CM, de Jong-Gerrits GCMM, van't Veer MB. AML-MO: clinical entity or waste basket for immature blastic leukemias? A description of 14 patients. Ann Hematol 1995; 70: 297-300.
28. Rubnitz JE, Behm FG, Downing JR. 11q23 rearrangements in acute leukemia. Leukemia 1996; 10: 74-82.
29. Sierra J, Brunet S, Grañena A, Olive T, Bueno J, Ribera JM, Petit J, Besses C, Llorente A, Guardia R, Macia J, Rovira M, Badell I, Vela E, Diaz Heredia C, Vivancos P, Carreras E, Feliu E, Montserrat E, Julia A, Cubells J, Rozman C, Domingo A, Ortega JJ. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloblastic leukemia. J Clin Oncol 1996; 14: 1353-1363.